Login to Your Account



Other News To Note


Tuesday, January 15, 2013
• Telik Inc., of Palo Alto, said ezatiostat HCL (Telintra) was granted orphan designation by the FDA for the treatment of myelodysplastic syndrome. Telintra is designed to inhibit enzyme glutathione S-transferase P1-1.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription